Alteration of fucosylation and biomarker development in lung cancer
| Project/Area Number |
22501029
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Tumor diagnosis
|
|---|
| Research Institution | Hokkaido University |
|---|
Principal Investigator |
AKITA Hirotoshi 北海道大学, 大学院・医学研究科, 教授 (70222528)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
KINOSHITA Ichiro 北海道大学, 大学院・医学研究科, 准教授 (40343008)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | バイオマーカー / 肺癌 / 糖鎖 / 糖転移酵素〓1-6fucosyltransferase / 非小細胞肺癌 / 糖転移酵素 / alfa 1-6フコース転移酵素 / alfa1,6-フコース転移酵素 / α1,6-フコース転移酵素 |
|---|
| Research Abstract |
High 〓1-6 fucosyltransferase (〓1-6 FucT) expression is more frequently found in adenocarcinomas than squamous cell carcinomas, and is correlated with advanced pN status in adenocarcinomas. High 〓1,6-FT expression is associated with an unfavorable clinical outcome in potentially curatively resected and pStage I adenocarcinomas. These findings suggest that 〓1,6-FT and its core-fucosylated products could be promisingbiomarkers and therapeutic targets for NSCLCs, especially for adenocarcinomas.
|
Report
(4 results)
Research Products
(6 results)
